(:NH)

Mar 21, 2023 09:00 am ET
NantHealth’s Eviti Connect Achieves HITRUST Risk-based, 2-year Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions transforming complex data into actionable insights, today announced its Eviti Connect solution has earned Certified status for information security by
Mar 06, 2023 09:00 am ET
NantHealth Announces $22.5 Million New Financing with Highbridge and Nant Capital
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the entry into a credit agreement for a new senior secured term loan in an aggregate principal amount of $22.5 million. The company intends to use the proceeds to continue funding its existing bus
Feb 22, 2023 09:00 am ET
OpenNMS releases OpenNMS Meridian 2023 with New Cloud-enabled Capabilities
The OpenNMS Group, Inc., a subsidiary of NantHealth, Inc. (NASDAQ: NH), today announced the rel
Dec 15, 2022 08:40 am ET
NantHealth Announces 1-for-15 Reverse Stock Split
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that the company has implemented a reverse stock split at a ratio of 1-for-15, which is expected to be effective 5 p.m. Eastern Time (ET) on December 15, 2022. The company’s common stock is expect
Nov 03, 2022 04:05 pm ET
NantHealth Reports 2022 Third Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its third quarter ended September 30, 2022.
Oct 31, 2022 04:50 pm ET
NantHealth to Report 2022 Third-Quarter Financial Results and Host Conference Call on Thursday, November 3
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 third quarter on Thursday, November 3, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Aug 24, 2022 09:00 am ET
NantHealth’s Eviti Platform Once More Earns Full URAC Accreditation Through 2025
NantHealth Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced it has been granted full URAC accreditation for Health Utilization Management for its Eviti Connect platform for another three years. NantHealth’s utilization management procedures
Aug 04, 2022 04:05 pm ET
NantHealth Reports 2022 Second Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2022.
Aug 01, 2022 06:53 am ET
NantHealth to Report 2022 Second-Quarter Financial Results and Host Conference Call on Thursday, August 4
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 second quarter on Thursday, August 4, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Jun 08, 2022 09:00 am ET
May 16, 2022 09:00 am ET
NantHealth NaviNet Open Wins “Healthcare Insurance Innovation Award” in 2022 MedTech Breakthrough Awards Program
NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that its
May 05, 2022 04:05 pm ET
NantHealth Reports 2022 First Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its first quarter ended March 31, 2022.
May 02, 2022 06:53 am ET
NantHealth to Report 2022 First-quarter Financial Results and Host Conference Call on Thursday, May 5
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2022 first quarter on Thursday, May 5, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Mar 31, 2022 09:00 am ET
The OpenNMS Group Releases OpenNMS Meridian 2022 with Enhanced Network Monitoring and Security Capabilities
The OpenNMS Group, Inc., a subsidiary of NantHealth, Inc. (NASDAQ: NH), today announced the releas
Mar 07, 2022 10:33 am ET
NantHealth to Present at the Cowen 42nd Annual Health Care Conference
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that members of its senior leadership team will participate in a fireside chat at the Cowen 42nd Annual Health Care Conference on Monday, March 7, 2022 at 2:50 p.m. ET, 11:50 a.m. PT.
Mar 07, 2022 09:00 am ET
NantHealth and Leading Nonprofit Multi-State Health Plan Scale Partnership to Increase Services for Members with Cancer
NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that
Mar 02, 2022 09:00 am ET
NantHealth’s NaviNet Open Payer-Provider Collaboration Platform Achieves HITRUST Certification to Further Mitigate Risk in Third-Party Privacy, Security and Compliance
HITRUST certified status demonstrates that NantHealth’s NaviNet Open platform has met key regulations and industry-defined requirements, and is appropriately managing risk. This achievement places NantHealth in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST Assurance Program helps organizations address security and data protection challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.
Feb 24, 2022 04:05 pm ET
NantHealth Reports 2021 Fourth-Quarter, Full-Year Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today reported financial results for its fourth quarter and full year ended December 31, 2021.
Feb 18, 2022 06:53 am ET
NantHealth to Report 2021 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, February 24
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 fourth quarter and full year on Thursday, February 24, 2022, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Nov 30, 2021 09:00 am ET
The OpenNMS Group Releases OpenNMS Minion Appliance – the Next Evolution of Distributed Monitoring
The OpenNMS Group, Inc., a NantHealth, Inc. (NASDAQ-GS: NH) subsidiary, today released its first OpenNMS Minion Appliance, which simplifies the deployment of OpenNMS Minion, the distributed monitoring component of OpenNMS. The appliance lets organizations quickly, reliably, and securely deploy Minions, extending the reach of the core monitoring system to remote or adjacent private networks.
Nov 16, 2021 09:00 am ET
Maryland Physicians Care (MPC) Selects NantHealth’s Eviti Connect to Validate Treatment For Members with Autoimmune Diseases
NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Maryland Physicians Care (MPC), an existing customer of the
Nov 04, 2021 04:07 pm ET
NantHealth to Participate at the 2021 Jefferies London Healthcare Conference
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that the company will participate at the 2021 Jefferies London Healthcare Conference.
Nov 04, 2021 04:06 pm ET
NantHealth Reports 2021 Third Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its third quarter ended September 30, 2021.
Nov 04, 2021 04:05 pm ET
NantHealth Expands, Strengthens Senior Management Team with Appointment of Three Key Executives
NantHealth, Inc. (NASDAQ: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the appointments of Jerry Magin as Senior Vice President of Global Sales and Marketing; Neil Carpenter as Senior Vice President of Strategy and Arlyn Small as Senior Vice President of Human R
Nov 01, 2021 06:54 am ET
NantHealth to Report 2021 Third-Quarter Financial Results and Host Conference Call on Thursday, November 4
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 third quarter on Thursday, November 4, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Oct 18, 2021 09:00 am ET
NantHealth Teams Up with Care Continuity for Patient Navigation and Care Coordination Across the Healthcare Continuum
NantHealth, Inc. (NASDAQ-GS: NH), a leading provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced an agreement with
Sep 29, 2021 08:00 am ET
NantHealth’s Chief Medical Officer to Educate on Advancing Equity in Cancer Care at the Oncology Clinical Pathways Congress 2021
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that Dr. Tiffany Avery, Chief Medical Officer, was selected to present a continuing education session at the Oncology Clinical Pathways Congress 2021. Dr. A
Sep 08, 2021 09:00 am ET
NantHealth and Intraprise Health Announce Collaboration to Help Providers Meet HIPAA Compliance Requirements and Protect Patient Data with HIPAA One Solution
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a collaboration with Intraprise Health, the provider of HIPAA One Security and Privacy Compliance software. HIPAA One’s Security Risk Assessment software will now be available to the growing network of healthcare provider offices utilizing NantHealth’s
Aug 05, 2021 04:05 pm ET
NantHealth Reports 2021 Second Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its second quarter ended June 30, 2021.
Aug 03, 2021 09:00 am ET
NantHealth Appoints Dr. Tiffany Avery as Chief Medical Officer
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the appointment of Tiffany Avery, MD, MPH, as Chief Medical Officer. In her new position, Dr. Avery will be responsible for providing clinical strategic direction and guiding the development and depl
Aug 02, 2021 06:52 am ET
NantHealth to Report 2021 Second-Quarter Financial Results and Host Conference Call on Thursday, August 5
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 second quarter on Thursday, August 5, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
May 06, 2021 04:05 pm ET
NantHealth Reports 2021 First Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that hel
May 05, 2021 09:00 am ET
NantHealth Launches Eviti Connect For Autoimmune Diseases
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help bus
May 04, 2021 06:55 am ET
NantHealth to Report 2021 First-Quarter Financial Results and Host Conference Call on Thursday, May 6
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2021 first quarter on Thursday, May 6, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Apr 14, 2021 06:00 am ET
NantHealth Announces $137.5 Million New Financing With Highbridge Capital Management and Nant Capital
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today announced the signing of a new financing that will include the issuance of $137.5 million aggregate principal amount of new senior unsecured convertible notes due 2026 (the "2026 Notes") in a
Mar 31, 2021 09:00 am ET
Feb 25, 2021 04:05 pm ET
NantHealth Reports 2020 Fourth-Quarter, Full-Year Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help transform complex data into actionable insights, today reported financial results for its fourth quarter and full year ended December 31, 2020.
Feb 22, 2021 06:52 am ET
NantHealth to Report 2020 Fourth-Quarter, Full-Year Financial Results and Host Conference Call on Thursday, February 25
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2020 fourth quarter and full year on Thursday, February 25, 2021, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Jan 25, 2021 08:00 am ET
NantHealth and Sesame Announce Collaboration to Help Providers Increase Productivity and Better Serve Patients
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced a collaboration with
Dec 09, 2020 09:00 am ET
NantHealth Presents Significant Treatment Insights at the 2020 San Antonio Breast Cancer Symposium in a Time of Need with the Pandemic’s Impact on Cancer Care
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today presented during a poster session at the
Nov 17, 2020 08:00 am ET
NantHealth and ImmunityBio Announce RNA Profiling for Clinical Decision Support Publication In Nature’s Scientific Reports
NantHealth, Inc. (NASDAQ: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced the publication of a study that revealed RNA sequencing is not only viable but may also provide significant clinical value in analyzing a cancer patient’s specific disease biology to enable an optimi
Nov 05, 2020 04:05 pm ET
NantHealth Reports 2020 Third Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today reported financial results for its third quarter ended September 30, 2020.
Oct 30, 2020 04:15 pm ET
NantHealth to Report 2020 Third-Quarter Financial Results and Host Conference Call on Thursday, November 5
NantHealth, Inc. (NASDAQ-GS: NH), a provider of enterprise solutions that help businesses transform complex data into actionable insights, today announced that it will report financial results for its 2020 third quarter on Thursday, November 5, 2020, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Oct 13, 2020 08:00 am ET
Combination of Deep-Learning Models Provides Significant Risk-Assessment of Survival in Pancreatic Cancer Patients, Holding Promise as a Prognostic Technology
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, presented virtually with NantOmics and ImmunityBio on September 29-30 2020, a session entitled “Deep-learning image-based tumor, stroma and lymphocytes spatial relationships and clinical features that affect survival in pancreatic cancer patients,” at t
Sep 23, 2020 08:00 am ET
NantHealth Enhances Interoperability of the NaviNet Open Platform With Expanded API Capabilities
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced a series of secure Application Programming Interfaces (APIs) that will offer provider and revenue cycle organizations connectivity to payers via the NaviNet Open Platform. This update enables faster information retrieval and easier payer access
Sep 22, 2020 09:15 am ET
NantHealth Rolls Out NaviNet AllPayer Platform Nationally
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the national rollout of
Aug 06, 2020 04:05 pm ET
NantHealth Reports 2020 Second Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its second quarter ended June 30, 2020.
Aug 03, 2020 11:47 am ET
NantHealth to Report 2020 Second-Quarter Financial Results and Host Conference Call on Thursday, August 6
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2020 second quarter on Thursday, August 6, 2020, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Jul 27, 2020 08:00 am ET
NantHealth Acquires OpenNMS, the World’s Largest Open Source Network Management Application Platform
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the acquisition of The
Jun 25, 2020 08:00 am ET
NantHealth Announces Research Results that Advances Understanding of Tumor Treatment Resistance
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced the publication of a study
Jun 18, 2020 04:00 pm ET
NantHealth Presented Clinical Data on Immunotherapy, Molecularly Targeted Agents and Tumor Biology at the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced the publication of four abstracts on developmental therapeutics for immunotherapy, molecularly targeted agents and tumor biology during the American Society of Clinical Oncology (ASCO) 2020 Virtual Scientific Program.
Jun 16, 2020 11:24 am ET
NantHealth to Exhibit at Virtual America’s Health Insurance Plans (AHIP) Institute & Expo 2020 with Webinars to Follow
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will exhibit at the online
May 08, 2020 04:30 pm ET
In Recognition of the Challenges Providers Are Facing, NantHealth is Offering Free Access to NaviNet AllPayer for a Limited Time
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will offer free access to the NaviNet AllPayer platform through May 31, 2020. There is no obligation when signing up and, for providers already subscribed to NaviNet AllPayer, free access for the month of May will occur automatically. Providers who are not Nav
May 07, 2020 04:05 pm ET
NantHealth Reports 2020 First Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its first quarter ended March 31, 2020.
May 04, 2020 06:52 am ET
NantHealth to Report 2020 First-quarter Financial Results and Host Conference Call on Thursday, May 7
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2020 first quarter on Thursday, May 7, 2020, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Feb 28, 2020 04:05 pm ET
NantHealth Reports 2019 Fourth-quarter, Full-year Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2019.
Feb 27, 2020 08:00 am ET
NantHealth’s Cancer Therapy Pre-Authorization Platform Eviti Connect® Starts 2020 Strong with Two Expanded Programs
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today two expanded programs with
Feb 25, 2020 08:00 am ET
Dr. Patrick Soon-Shiong to Deliver Keynote at HIMSS 2020 Intelligent Health™ Pavilion
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare technology company, announced today that Dr. Patrick Soon-Shiong, Chairman and CEO, has been chosen to keynote at the Intelligent Health™ Pavilion (IHP) during the Healthcare Information Management Systems Society (HIMSS) 2020 Annual Conference & Exhibition in
Feb 24, 2020 06:54 am ET
NantHealth to Report 2019 Fourth-Quarter Financial Results and Host Conference Call on Friday, February 28
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 fourth quarter on Friday, February 28, 2020, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Jan 28, 2020 06:33 pm ET
The Health Plan Serving Over 200,000 Covered Lives Selects NantHealth’s NaviNet® Open to Drive Provider Engagement Strategy
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced its partnership with
Jan 28, 2020 08:00 am ET
The Health Plan Serving Over 200,000 Covered Lives Selects NantHealth’s NaviNet® Open to Drive Provider Engagement Strategy
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced its partnership with
Jan 27, 2020 07:10 pm ET
Jan 25, 2020 09:30 am ET
Data from NantHealth’s GPS Cancer platform reveals increased opportunities for HER2 directed therapy in colorectal cancer patients
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced Results of a fifty-gene breast cancer RNA subtype classifier applied to 167 colorectal cancer (CRC) patients during a poster session at the
Jan 25, 2020 09:30 am ET
Jan 14, 2020 09:00 am ET
Masimo to Acquire Connected Care Business from NantHealth
Masimo (NASDAQ: MASI), a global leader in noninvasive monitoring technologies, and NantHealth, Inc. (NASDAQ: NH), a next-ge
Dec 11, 2019 06:00 pm ET
NantHealth Presents Research Demonstrating Real World Evidence of Simultaneous Presentation and Publication of Oncology Data at the 2019 San Antonio Breast Cancer Symposium
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced new breast cancer research findings presented during a poster session at the
Nov 12, 2019 08:00 am ET
Nov 07, 2019 04:15 pm ET
NantHealth Reports 2019 Third-Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its third quarter ended September 30, 2019.
Oct 30, 2019 06:54 am ET
NantHealth to Report 2019 Third-quarter Financial Results and Host Conference Call on Thursday, November 7
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 third quarter on Thursday, November 7, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Oct 23, 2019 05:00 am ET
Wexford Health Sources, Inc. Selects NantHealth’s Eviti® Connect to Bring Evidence-Based Standards and Value-Based Oncology Care to Patients
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today its new customer, W
Oct 04, 2019 08:00 am ET
NantHealth®, GE Healthcare, AirStrip and iProcedures Join Forces to Present at the HIMSS Asia Pacific 2019 Conference
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today it will be presenting with G
Sep 26, 2019 04:30 am ET
NantHealth Announces New Product Updates to Help Reduce Patient Overstays and Facilitate Faster Decision Making at AMSN’s 28th Annual Convention
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, announced today at the
Aug 27, 2019 08:00 am ET
NantHealth’s Eviti Platform Again Granted Full URAC Accreditation, Through September 1, 2022
NantHealth Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it has been granted full URAC accreditation for Health Utilization Management for its
Aug 08, 2019 04:15 pm ET
NantHealth Reports 2019 Second-Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its second quarter ended June 30, 2019.
Aug 01, 2019 06:54 am ET
NantHealth to Report 2019 Second-Quarter Financial Results and Host Conference Call on Thursday, August 8
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 second quarter on Thursday, August 8, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Jun 19, 2019 11:00 am ET
NantHealth to Exhibit at America’s Health Insurance Plans (AHIP) Institute & Expo 2019
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will be exhibiting at
Jun 13, 2019 08:00 am ET
CareSource, One of the Nation’s Largest Medicaid Managed Care Plans, Selects NantHealth’s Eviti® Connect to Provide Members with Quality, Value-Based Oncology Care
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, today announced its partnership with
Jun 12, 2019 01:00 am ET
NantHealth® Showcases Leading Health Care Technology Solutions at First U.S. Pavilion at HIMSS & Health 2.0 European Conference
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized health care company, will be exhibit
Jun 11, 2019 01:46 am ET
NantHealth® Showcases Connected Care Products at HIMSS & Health 2.0 European Conference 2019
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized health care company, showcases
Jun 03, 2019 09:04 am ET
May 21, 2019 11:15 am ET
NantHealth® Showcases DeviceConX™ Version 5.15 at Vitalis, Largest eHealth Event in Scandinavia
NantHealth, Inc. (NASDAQ: NH), a leader in connected care solutions, showcases DeviceConX™ Version 5.15 at Vitalis, one of the largest e-health events in Scandinavia. NantHealth’s Connected Care solutions integrate medical device data into clinical records which may lead to reduced length of stay, less costly medical er
May 21, 2019 11:08 am ET
NantHealth Discusses the Importance of Medical Device Integration at Vitalis 2019
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will showcase high-impact content throughout this year’s
May 09, 2019 04:15 pm ET
NantHealth Reports 2019 First-Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its first quarter ended March 31, 2019.
May 02, 2019 06:54 am ET
NantHealth to Report 2019 First-Quarter Financial Results and Host Conference Call on Thursday, May 9
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2019 first quarter on Thursday, May 9, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Apr 12, 2019 08:55 am ET
Detailed Research: Economic Perspectives on Global Brass and Copper, Lannett, NantHealth, Ballantyne Strong, Barnwell Industries, and Chicago Rivet & Machine — What Drives Growth in Today's Competitiv
In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of Global Brass and Copper Holdings, Inc. (NYSE:BRSS), Lannett Co Inc (NYSE:LCI),...
Apr 10, 2019 08:00 am ET
NantHealth® Showcases Connected Care Benefits to Improve Medical Device Data Collection at the American Nursing Informatics Association (ANIA) Annual Conference
NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will present on Connected Care
Mar 28, 2019 04:15 pm ET
NantHealth Reports 2018 Fourth-Quarter, Full-Year Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its fourth quarter ended December 31, 2018.
Mar 25, 2019 02:00 pm ET
NantHealth to Report 2018 Fourth-Quarter Financial Results and Host Conference Call on Thursday, March 28
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 fourth quarter on Thursday, March 28, 2019, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Mar 18, 2019 08:00 am ET
NantHealth® and Northwest Fire Fighters Benefits Trust (NWFFT) Join Forces to Provide GPS Cancer® and Liquid GPS to Trust Covered Members
NantHealth, Inc. (NASDAQ: NH), announced an agreement with Northwest Fire Fighters Benefits Trust (NWFFT), one of the largest firefighter healthcare trusts in the U.S., to ensure all NWFFT covered plan members with access to NantHealth’s GPS Cancer and Liquid GPS molecular profiling tests. Comprehensive molecular information may enable physicians to make personalized treatment strategies for cancer based on the individual’s tumor and genetic profile. NWFFT is present in the states of Alaska, Connecticut, Idaho, Illinois, Nevada and Washington.
Feb 12, 2019 08:00 am ET
NantHealth® Debuts Multiple Connected Care Initiatives at HIMSS
NantHealth, Inc. (NASDAQ: NH), a leader in connected care solutions, will unveil a series of new initiatives designed to improve patient outcomes and provider satisfaction at the 2019 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and Exhibition taking place this week in Orlando. NantHealth’s main booth location will be #4944. The company will also be featured in the HIMSS Interoperability Showcase™ and the Intelligent Health Pavilion™. NantHealth’s executive, Wesley Madden, BSN, RN, Vice President of Conn
Feb 11, 2019 08:00 am ET
Baxter and NantHealth® Advance Digital Health Technology for Medical Devices in the Hospital ICU
NantHealth (NASDAQ: NH), a leader in connected care solutions, and Baxter International Inc. (NYSE:BAX), a global medical products company, today announced that a NantHealth digital health solution is now available to connect Baxter’s Prismaflex system to a hospital electronic medical record (EMR). Prismaflex is used in the intensive care unit (ICU) to treat patients with acute kidney injury (AKI) and certain blood and autoimmune conditions, which can be life-threatening. The companies are demonstrating the technology at the
Dec 03, 2018 07:00 am ET
NantHealth® to Present New Research Findings at the San Antonio Breast Cancer Symposium
Significant developments in breast cancer research will be presented by NantHealth (NASDAQ: NH) at the San Antonio Breast Cancer Symposium this week. NantHealth, a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, will discuss the findings of three investigations, which examine the theme of providing oncologists with insights that enable cancer treatment tailored to the individual characteristics of each patient.
Nov 28, 2018 09:00 am ET
Report: Exploring Fundamental Drivers Behind Matrix Service, NantHealth, Earthstone Energy, Jounce Therapeutics, BeiGene, and Oxford Immunotec Global — New Horizons, Emerging Trends, and Upcoming Deve
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Matrix Service Company (NASDAQ:MTRX), NantHealth, Inc. (NASDAQ:NH),...
Nov 15, 2018 04:15 pm ET
NantHealth Reports 2018 Third-Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its third quarter ended September 30, 2018.
Nov 07, 2018 02:24 pm ET
NantHealth® Advances Clinician Productivity and Critical Patient Information Access with Enhancements to DeviceConX™
NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and data solutions that improve patient care and lower healthcare costs, today announced updates to its
Nov 07, 2018 02:24 pm ET
NantHealth®, B. Braun Australia, GE Healthcare and iProcedures Join Forces to Bridge Connectivity Gap Between Patient Devices, Data and Medical Records at the Healthcare Information and Management Sys
NantHealth (NASDAQ: NH), a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, today announced a collaboration with B. Braun Australia, GE Healthcare and iProcedures to demonstrate the exchange of data between devices and patient electronic medical records (EMRs).
Nov 07, 2018 06:54 am ET
NantHealth to Report 2018 Third-Quarter Financial Results and Host Conference Call on Thursday, November 15
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 third quarter on Thursday, November 15, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance. The company intends to file its Quarterly Report on Form 10-Q for the three and nine months ended September 30, 2018 on or before November 23, 2018.
Oct 29, 2018 08:00 am ET
NantHealth and NantOmics Present Four Research Papers Demonstrating Advancements in Cancer Diagnostics with NantHealth’s GPS Cancer® and Liquid GPS™
Significant developments in cancer research were presented by NantHealth (NASDAQ: NH) and NantOmics at the ESMO conference in Munich, Germany this week. NantHealth, a leader in breakthrough cancer research and solutions to improve patient care and lower healthcare costs, in conjunction with NantOmics, a leader in molecular diagnostic testing, conducted one oral presentation and four papers, including a few demonstrating the promise of the company’s Liquid GPS™, a blood-based molecular test that provides oncologists with a powerful
Oct 19, 2018 09:10 am ET
New Research: Key Drivers of Growth for Teva Pharmaceutical Industries, Axovant Sciences, SolarEdge Technologies, NantHealth, Kosmos Energy, and Retrophin — Factors of Influence, Major Initiatives and
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Axovant Sciences Ltd....
Sep 07, 2018 08:00 am ET
NantHealth Announces Appointment of Two Senior Executives to Lead Strategy, Business Development, and Global Sales
NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, announced new executive appointments to lead the company’s strategy and business development as well as global sales.
Aug 27, 2018 03:37 pm ET
Using the Technology That Powers GPS Cancer™, Scientists Have Developed Fresh Insights into the Driving Mechanisms of a Rare Skin Cancer
New, peer-reviewed research utilizing NantOmics technology, which powers NantHealth’s (NASDAQ: NH) GPS Cancer ® is giving scientists fresh insights into the driving mechanisms behind a form of rare skin cancer as well as therapies to treat patients.
Aug 21, 2018 07:35 am ET
Consolidated Research: 2018 Summary Expectations for GSV Capital, NantHealth, Gold Fields, Sogou Inc. Sponsored ADR, Clementia Pharmaceuticals, and Arbutus Biopharma — Fundamental Analysis, Key Perfor
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of GSV Capital Corp (NASDAQ:GSVC), NantHealth, Inc. (NASDAQ:NH), Gold Fields...
Aug 09, 2018 04:15 pm ET
NantHealth Reports 2018 Second-Quarter Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its second quarter ended June 30, 2018.
Aug 03, 2018 06:54 am ET
NantHealth to Report 2018 Second-Quarter Financial Results and Host Conference Call on Thursday, August 9
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 second quarter on Thursday, August 9, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Jul 31, 2018 07:03 am ET
SHAREHOLDER ALERT: Hynes Keller & Hernandez, LLC Announces Investigation of NantHealth, Inc. (NH) and FleetCor Technologies, Inc. (FLT)
NEW YORK, July 31, 2018 /PRNewswire/ --  Hynes Keller & Hernandez, LLC is investigating potential claims against the Board of Directors of NantHealth, Inc. (NASDAQ: NH) concerning possible breaches of fiduciary duty that the Company's founder, Patrick Soon-Shiong, allegedly donated funds through nonprofit organizations to the University of Utah for the purpose of funneling those funds back into NantHealth.
Jun 20, 2018 03:24 pm ET
NantHealth Unveils New Collaboration Tools - Provider Initiated Document Exchange and Authorization Appeals
NantHealth, Inc. (NASDAQ: NH) announced two exciting new product launches - Provider Initiated Document Exchange and Authorization Appeals - on the nation’s leading payer-provider collaboration platform, NaviNet® Open, at the 2018 AHIP Institute and Expo.
Jun 19, 2018 08:01 pm ET
NantHealth to Present and Exhibit on the Convergence of Precision Medicine and Value-Based Care at America’s Health Insurance Plans (AHIP) Institute & Expo 2018
NantHealth (NASDAQ: NH), a next-generation healthcare company, will exhibit and present at America’s Health Insurance Plans (
Jun 06, 2018 07:45 am ET
New Research Coverage Highlights Materialise NV, MacroGenics, GasLog Partners LP, TCP Capital, NantHealth, and Net 1 UEPS Technologies — Consolidated Revenues, Company Growth, and Expectations for 201
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Materialise NV (NASDAQ:MTLS), MacroGenics, Inc. (NASDAQ:MGNX), GasLog...
Jun 02, 2018 05:23 pm ET
NantHealth and NantOmics to Present Data on the Frequency of Non-Expressed Variants Tested by Standard NGS Panel at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evide
Jun 02, 2018 05:19 pm ET
NantHealth and NantOmics to Present Patterns of Immune Checkpoint Molecules in Relation to PD-L1 Expression at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evide
Jun 02, 2018 05:03 pm ET
Jun 02, 2018 05:02 pm ET
NantHealth and NantOmics to Share Data on Next-Generation Sequencing of Paired DNA and RNA Analysis of Rare Tumors at the American Society of Clinical Oncology (ASCO) 2018 Annual Meeting
NantWorks, LLC today announced that its affiliate companies, NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evide
Jun 02, 2018 07:00 am ET
NantHealth Unveils Liquid GPS™, Powerful Next-Generation Tool for Blood-Based Tumor Profiling and Quantitative Monitoring
NantHealth, Inc. (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, unveiled Liquid GPS™ a powerful next-generation tool for blood-based tumor profiling and quantitative monitoring.
May 30, 2018 06:52 am ET
NantHealth to Present at the Jefferies 2018 Global Healthcare Conference on June 6
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its management will be presenting at the Jefferies 2018 Global Healthcare Conference on Wednesday, June 6, 2018, at 4 p.m. ET in New York City.
May 21, 2018 12:30 pm ET
NantOmics Announces Study Showing Signature Analysis That Reveals Three Distinct Classifications of Skin Cancer Known as Sebaceous Carcinoma
NantOmics, LLC, the leader in molecular analyses and a member of the NantWorks ecosystem of companies, announced today the publication of peer-reviewed research defining for the first time three distinct classifications of sebaceous carcinoma, a rare and sometimes deadly former of skin cancer.
May 17, 2018 02:12 am ET
NantHealth to Present at the Bank of America Merrill Lynch Health Care Conference 2018 on May 17
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its management will be presenting at the Bank of America Merrill Lynch 2018 Health Care Conference on Thursday, May 17, 2018, at 11:20 a.m. PT in Las Vegas.
May 14, 2018 02:10 pm ET
NantHealth Showcases and Presents Its Portfolio of Medical Device Integration (MDI) Products to Provide Current and Future Insights to Patient Care at the Largest E-Health Event in Scandinavia
NantHealth (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, showcased their Connected Care solutions at Vitalis, the largest e-health event in Scandinavia. The conference took place on April 24-26 at the Swedish Exhibition and Congress Centre in Gothenburg, Sweden.
May 14, 2018 12:29 pm ET
The Shuman Law Firm Investigates NantHealth, Inc.
The Shuman Law Firm announces that it is investigating potential shareholder claims against certain officers and directors of NantHealth, Inc. (“NantHealth” or the “Company”) (Nasdaq:
May 09, 2018 08:39 pm ET
CORRECTING and REPLACING NantHealth Reports 2018 First-Quarter Financial Results
Changes have been made to the "Supplemental Revenue Schedule" and "Non-GAAP Net Loss and Non-GAAP Net Loss Per Share" financial tables.
May 07, 2018 08:00 am ET
NantHealth and NantOmics Announce Publication of Study Highlighting High Error Rates in Tumor-Only Sequencing for Cancer Treatment
NantHealth, Inc., (NASDAQ: NH), a leading next-generation, evidence-based, personalized healthcare company, and NantOmics,
May 04, 2018 06:52 am ET
NantHealth to Report 2018 First-Quarter Financial Results and Host Conference Call on Wednesday, May 9
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2018 first quarter on Wednesday, May 9, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Apr 10, 2018 07:35 am ET
Factors of Influence in 2018, Key Indicators and Opportunity within Global Blood Therapeutics, Wix, Changyou, BT Group, Golar LNG, and NantHealth — New Research Emphasizes Economic Growth
NEW YORK, April 10, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Global Blood Therapeutics, Inc. (NASDAQ:GBT), Wix.com...
Mar 16, 2018 08:25 am ET
Report: Developing Opportunities within Itau Unibanco Banco Holding SA, NantHealth, Southern First Bancshares, uniQure N.V., Ascendis Pharma A/S, and National General — Future Expectations, Projection
NEW YORK, March 16, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Itau Unibanco Banco Holding SA (NYSE:ITUB),...
Mar 14, 2018 04:15 pm ET
NantHealth Reports 2017 Fourth-Quarter and Full-Year Financial Results
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its fourth quarter and full year ended December 31, 2017.
Mar 09, 2018 06:54 am ET
NantHealth to Report 2017 Fourth-Quarter and Full-Year Financial Results and Host Conference Call on Wednesday, March 14
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 fourth quarter and full year on Wednesday, March 14, 2018, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Mar 05, 2018 03:30 pm ET
NantHealth to Present on the Future of Device Connectivity across the Continuum of Care at HIMSS18
NantHealth (NASDAQ: NH), a next-generation, evidence-based, personalized healthcare company, will be exhibiting this year at the Healthcare Information & Management Systems Society Annual Conference & Exhibition 2018 (
Jan 05, 2018 06:03 pm ET
NantWorks to Present Healthcare and Biotechnology Platforms at 36th Annual J.P. Morgan Healthcare Conference on January 9, 2018 in San Francisco, CA
NantWorks, the parent organization of NantHealth (NASDAQ: NH) and NantKwest (NASDAQ: NK) announced today that Dr. Patrick Soon-Shiong (Chairman, CEO, and Founder) will present the current status of these companies and the overall ecosystem of NantWorks. Specific details will be presented regarding the current status of GPS CancerT
Dec 04, 2017 08:00 am ET
NantHealth to Support the University of California San Francisco in Research Initiative Focused on Metastatic Breast Cancer
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced its support for a research study initiated by the
Nov 15, 2017 08:00 am ET
NantHealth Ranked Number 304 Fastest Growing Company in North America on Deloitte’s 2017 Technology Fast 500™
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, announced today a ranking of 304 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America.
Nov 09, 2017 04:05 pm ET
NantHealth Reports 2017 Third Quarter Financial Results; GPS Revenue Doubles from Preceding Quarter
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today reported financial results for its third quarter ended September 30, 2017.
Nov 03, 2017 06:57 am ET
NantHealth to Report 2017 Third-Quarter Financial Results and Host Conference Call on Thursday, November 9
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that it will report financial results for its 2017 third quarter on Thursday, November 9, 2017, after market close. NantHealth management will host a conference call that same day at 1:30 p.m. PT (4:30 p.m. ET) to review the company’s performance.
Oct 25, 2017 07:00 am ET
NantHealth’s Vitality Mobile App Now Available on Apple and Android Devices
NantHealth, Inc. (NASDAQ-GS: NH), a next-generation, evidence-based, personalized healthcare company, today announced that its Vitality Mobile app is now available for download through the Apple and Google Play Stores. When linked with
May 03, 2017 02:20 pm ET
DEADLINE ALERT: Brower Piven Reminds Investors Of The Upcoming Deadline In Class Action Lawsuit And Encourages Investors With Losses In Excess of $100,000 From Investment In NantHealth, Inc. (Nasdaq:N
STEVENSON, Md., May 03, 2017 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of NantHealth, Inc. (Nasdaq:NH) (“NantHealth” or the “Company”) securities pursuant or traceable to the Company’s initial public offering on June 1, 2016 (the “IPO”) or between June 1, 2016 and March 6, 2017, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation hav...
May 02, 2017 04:47 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Claims Against NantHealth, Inc. - NH
NEW YORK, May 2, 2017 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of NantHealth, Inc. securities (NASDAQ: NH): (1) pursuant or traceable to NantHealth's initial public offering on or about June 1, 2016; and/or (2) from June 1, 2016 through March 6, 2017, inclusive (the "Class Period"). The lawsuit seeks to recover damages for NantHealth investors under the federal securities laws.
Apr 28, 2017 10:50 pm ET
NANTHEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
NEW ORLEANS, April 28, 2017 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until May 8, 2017 to file lead plaintiff applications in a securities class action lawsuit against NantHealth, Inc. (Nasdaq:NH), if they purchased the Company’s securities pursuant or traceable to the Company’s initial public offering on June 1, 2016 (the “IPO”) or between June 1, 2016 and March 6, 2017, inclusive (the “Class Period”). The action is pending in United States District Court for the C...
Apr 27, 2017 01:44 pm ET
Scott+Scott, Attorneys at Law, LLP Reminds Investors of Upcoming May 8th Deadline to File for Lead Plaintiff in Class Action Lawsuit against NantHealth, Inc. (NH)
NEW YORK, April 27, 2017 /PRNewswire/ -- Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, reminds investors that that a federal securities lawsuit has been filed against NantHealth, Inc. (NASDAQ: NH) ("NantHealth" or the "Company"), a corporation headquartered in California and incorporated in Delaware, and certain of its senior officers and directors.  If you purchased NantHealth stock (1) pursuant and/or traceable to the Company's initial public offering ("IPO") on or about June 1, 2016; and/or (2) between June 1, 2016 and Marc
Apr 26, 2017 04:49 pm ET
SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit against NantHealth, Inc. and Reminds Investors with Losses to Contact the Firm
LOS ANGELES, April 26, 2017 /PRNewswire/ -- Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against NantHealth ("NantHealth" or the "Company") (Nasdaq: NH) concerning possible violations of federal securities laws. Investors who purchased shares (1) pursuant and/or traceable to the Company's initial public offering ("IPO") on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017 inclusive (the "Class Period") should contact the firm prior to the May 8, 2017 lead plaintiff motion deadline.
Apr 25, 2017 04:35 pm ET
NH INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against NantHealth, Inc. and Reminds Investors with Losses to Contact the Firm
IRVINE, Calif., April 25, 2017 /PRNewswire/ -- Khang & Khang LLP (the "Firm") announces a class action lawsuit against NantHealth, Inc. ("NantHealth" or the "Company") (Nasdaq: NH). Investors who purchased shares (1) pursuant and/or traceable to the Company's initial public offering ("IPO") on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017 inclusive (the "Class Period"), are encouraged to contact the Firm in advance of the May 8, 2017 lead plaintiff motion deadline.
Apr 24, 2017 02:31 pm ET
The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of NantHealth, Inc. Shareholders and a Lead Plaintiff Deadline of May 8, 2017
NEW YORK, April 24, 2017 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of NantHealth, Inc. (NASDAQ:NH) who purchased shares (1) pursuant and/or traceable to the Company’s initial public offering on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017. The action, which was filed in the United States District Court for the Central District of California, alleges that the Company violated federal securities laws....
Apr 21, 2017 01:53 pm ET
APPROACHING DEADLINE: Khang & Khang LLP Announces Securities Class Action Lawsuit against NantHealth, Inc. and Reminds Investors with Losses to Contact the Firm
IRVINE, Calif., April 21, 2017 (GLOBE NEWSWIRE) -- Khang & Khang LLP (the “Firm”) announces a class action lawsuit against NantHealth, Inc. (“NantHealth” or the “Company”) (Nasdaq:NH). Investors who purchased shares (1) pursuant and/or traceable to the Company’s initial public offering (“IPO”) on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017 inclusive (the “Class Period”), are encouraged to contact the Firm in advance of the May 8, 2017 lead plaintiff motion deadline....
Apr 21, 2017 11:52 am ET
NH INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving NantHealth, Inc. and a Lead Plaintiff Deadline of May 8, 2017
NEW YORK, April 21, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased NantHealth, Inc. (NASDAQ:NH) securities (1) pursuant and/or traceable to the Company’s Initial Public Offering on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017....
Apr 20, 2017 02:40 pm ET
Scott+Scott, Attorneys at Law, LLP Informs Investors of Class Action Lawsuit against NantHealth, Inc. (NH) and May 8th Deadline to File for Lead Plaintiff
NEW YORK, April 20, 2017 /PRNewswire/ -- Scott+Scott, Attorneys at Law, LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, announces that a federal securities lawsuit has been filed against NantHealth, Inc. (NASDAQ: NH) ("NantHealth" or the "Company"), a corporation headquartered in California and incorporated in Delaware, and certain of its senior officers and directors.  If you purchased NantHealth stock (1) pursuant and/or traceable to the Company's initial public offering ("IPO") on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017, yo
Apr 19, 2017 04:30 pm ET
Apr 10, 2017 05:39 pm ET
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Claims Against NantHealth, Inc. – NH
NEW YORK, April 10, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of NantHealth, Inc. securities (NASDAQ:NH): (1) pursuant or traceable to NantHealth’s initial public offering on or about June 1, 2016; and/or (2) from June 1, 2016 through March 6, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for NantHealth investors under the federal securities laws....
Apr 03, 2017 07:37 pm ET
EQUITY ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against NantHealth, Inc. and Reminds Investors with Losses to Contact the Firm
IRVINE, Calif., April 03, 2017 (GLOBE NEWSWIRE) -- Khang & Khang LLP (the “Firm”) announces a class action lawsuit against NantHealth, Inc. (“NantHealth” or the “Company”) (Nasdaq:NH). Investors who purchased shares (1) pursuant and/or traceable to the Company’s initial public offering (“IPO”) on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017 inclusive (the “Class Period”), are encouraged to contact the Firm prior to the May 8, 2017 lead plaintiff motion deadline....
Apr 03, 2017 04:44 pm ET
SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In NantHealth, Inc. (NH) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class
STEVENSON, Md., April 03, 2017 (GLOBE NEWSWIRE) -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Central District of California on behalf of purchasers of NantHealth, Inc. (Nasdaq:NH) (“NantHealth” or the “Company”) securities pursuant or traceable to the Company’s initial public offering on June 1, 2016 (the “IPO”) or between June 1, 2016 and March 6, 2017, inclusive (the “Class Period”).  Investors who wish to become proactively involved in the litigation...
Mar 31, 2017 11:50 pm ET
NANTHEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
NEW ORLEANS, March 31, 2017 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until May 8, 2017 to file lead plaintiff applications in a securities class action lawsuit against NantHealth, Inc. (NasdaqGS: NH), if they purchased the Company's securities pursuant or traceable to the Company's initial public offering on June 1, 2016 (the "IPO") or between June 1, 2016 and March 6, 2017, inclusive (the "Class Period").  The action is pending in United States District Court for the C
Mar 31, 2017 06:33 pm ET
IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against NantHealth, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, March 31, 2017 (GLOBE NEWSWIRE) -- Lundin Law PC , a shareholder rights firm, announces a class action lawsuit against NantHealth (“NantHealth” or the “Company”) (Nasdaq:NH) concerning possible violations of federal securities laws. Investors who purchased shares (1) pursuant and/or traceable to the Company’s initial public offering (“IPO”) on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017 inclusive (the “Class Period”) should contact the firm prior to the May 8, 2017 lead plaintiff motion deadline....
Mar 31, 2017 06:04 pm ET
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In NantHealth, Inc. To Contact The Firm
NEW YORK, March 31, 2017 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ:NH) of the May 8, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers.
Mar 24, 2017 05:33 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NantHealth, Inc. of Class Action Lawsuit and Upcoming Deadline – NH
NEW YORK, March 24, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NantHealth, Inc. (“NantHealth” or the “Company”) (NASDAQ:NH) and certain of its officers.  The class action, filed in United States District Court, Central District of California, and docketed under 17-cv-1824, is on behalf of a class consisting of investors who purchased or otherwise acquired NantHealth securities: (1) pursuant and/or traceable to NantHealth’s false and misleading Registration Statement and Prospectus, issued in connection with the Company’s initial publ...
Mar 24, 2017 03:59 pm ET
NantHealth Investor Deadline Reminder: Hagens Berman Reminds Investors in NantHealth of the IPO-Related Securities Class Action and the May 6, 2017 Lead Plaintiff Deadline
SAN FRANCISCO, March 24, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP reminds investors in NantHealth, Inc. (NASDAQ:NH) of the pending IPO-related securities class action and the May 6, 2017 Lead Plaintiff deadline....
Mar 20, 2017 11:45 am ET
NH SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving NantHealth, Inc. and a Lead Plaintiff Deadline of May 8, 2017
NEW YORK, March 20, 2017 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the Central District of California on behalf of investors who purchased NantHealth, Inc. (NASDAQ:NH) securities (1) pursuant and/or traceable to the Company’s Initial Public Offering on or about June 1, 2016; and/or (2) between June 1, 2016 and March 6, 2017....
Mar 17, 2017 10:50 pm ET
NANTHEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until May 8, 2017 to file lead plaintiff applications in a securities class action lawsuit against...
Mar 17, 2017 08:28 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in NantHealth, Inc. of Class Action Lawsuit and Upcoming Deadline - NH
NEW YORK, March 17, 2017 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH) and certain of its officers.   The class action, filed in United States District Court, Central District of California, and docketed under 17-cv-1824, is on behalf of a class consisting of investors who purchased or otherwise acquired NantHealth securities: (1) pursuant and/or traceable to NantHealth's false and misleading Registration Statement and Prospectus, issued in connection with the Company's initial public o
Mar 17, 2017 06:00 pm ET
IMPORTANT NANTHEALTH, INC. INVESTOR ALERT: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed against NantHealth, Inc. in the Central Di
NEW YORK, March 17, 2017 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP   announces that a class action lawsuit has been filed in the United States District Court for the Central District of California on behalf of purchasers of NantHealth, Inc. securities (NASDAQ:NH) (“NantHealth” or the “Company”): (1) pursuant or traceable to NantHealth’s initial public offering on or about June 1, 2016; and/or (2) from June 1, 2016 through March 6, 2017, inclusive (the “Class Period”)....
Mar 15, 2017 04:17 pm ET
Mar 15, 2017 03:48 pm ET
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In NantHealth, Inc. To Contact The Firm Before Lead Plaintiff Deadline
NEW YORK, March 15, 2017 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in NantHealth, Inc. (“NantHealth” or the “Company”) (NASDAQ:NH) of the May 8, 2017 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against the Company and certain officers....
Mar 15, 2017 01:17 pm ET
WeissLaw LLP: NantHealth, Inc. (NH) is the Subject of a Legal Investigation
NEW YORK, March 15, 2017 /PRNewswire/ -- WeissLaw LLP, a national class action and shareholders' rights law firm with offices in New York and Los Angeles, announces an investigation of NantHealth, Inc. ("NantHealth," or the "Company") (NASDAQ: NH), its Board of Directors, and certain Company officers for, among other things, possible breaches of fiduciary duty and violations of federal securities laws.
Mar 11, 2017 04:19 pm ET
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against NantHealth, Inc.
OKLAHOMA CITY, March 11, 2017 (GLOBE NEWSWIRE) -- Federman & Sherwood announces that on March 7, 2017, a class action lawsuit was filed in the United States District Court for the Central District of California against NantHealth, Inc. (NASDAQ:NH). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is tracea...
Mar 10, 2017 10:50 pm ET
NANTHEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against
NEW ORLEANS, March 10, 2017 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., reminds investors that they have until May 8, 2017 to file lead plaintiff applications in a securities class action lawsuit against NantHealth, Inc. (Nasdaq:NH), if they purchased the Company’s securities pursuant or traceable to the Company’s initial public offering on June 1, 2016 (the “IPO”) or between June 1, 2016 and March 6, 2017, inclusive (the “Class Period”).  The action is pending in United States District Court for the ...
Mar 10, 2017 04:00 pm ET
UPDATE: NantHealth Investor Alert: Hagens Berman Alerts Investors in NantHealth to the IPO-Related Securities Class Action and the May 6, 2017 Lead Plaintiff Deadline
SAN FRANCISCO, March 10, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in NantHealth, Inc. (NASDAQ:NH) to the IPO-related securities class action pending in the U.S. District Court for the Central District of California and to the May 6, 2017 Lead Plaintiff deadline....
Mar 09, 2017 05:01 pm ET
Harwood Feffer LLP Announces Investigation of NantHealth, Inc.
NEW YORK, March 9, 2017 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH) concerning whether the board has breached its fiduciary duties to shareholders.
Mar 09, 2017 04:00 pm ET
NantHealth Investor Alert: Hagens Berman Alerts Investors in NantHealth to the Pending Securities Class Action and the May 6, 2017 Lead Plaintiff Deadline
SAN FRANCISCO, March 09, 2017 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors in NantHealth, Inc. (NASDAQ:NH) to the securities class action pending in the U.S. District Court for the Central District of California and to the May 6, 2017 Lead Plaintiff deadline....
Mar 08, 2017 08:02 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against NantHealth, Inc. (NH)
NEW YORK, March 08, 2017 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a class action lawsuit has been filed against NantHealth, Inc. (“NantHealth” or the “Company”) (Nasdaq:NH) in the United States District Court for the Central District of California on behalf of a class consisting of investors who purchased or otherwise acquired NantHealth securities: (1) pursuant and/or traceable to NantHealth’s false and misleading Registration Statement and Prospectus, issued in connection with the Company’s initial public offering on or about June 2, 2016 (the “IPO” or the “Offering...
Mar 08, 2017 10:10 am ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against NantHealth, Inc. (NH) & Lead Plaintiff Deadline: May 8, 2017
NEW YORK, March 8, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH) and certain of its officers, and is on behalf of a class consisting of all persons or entities who purchased NantHealth securities (1) pursuant and/or traceable to NantHealth's false and misleading Registration Statement and Prospectus, issued in connection with the Company's initial public offering on or about June 2, 2016 (the "IPO" or the "Offering"); and/or
Mar 07, 2017 08:00 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against NantHealth, Inc. and Certain Officers – NH
NEW YORK, March 07, 2017 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against NantHealth, Inc. (“NantHealth” or the “Company”) (NYSE:NH) and certain of its officers.  The class action, filed in United States District Court, Central District of California, and docketed under 17-cv-1824, is on behalf of a class consisting of investors who purchased or otherwise acquired NantHealth securities: (1) pursuant and/or traceable to NantHealth’s false and misleading Registration Statement and Prospectus, issued in connection with the Company’s initial public o...
Mar 07, 2017 03:02 pm ET
RM LAW Announces Investigation of NantHealth, Inc.
BERWYN, Pa., March 7, 2017 /PRNewswire/ -- RM LAW, P.C. is investigating potential claims against the board of directors of NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH).  Our investigation concerns potential breach of fiduciary duty and securities claims. 
Mar 07, 2017 09:25 am ET
NANTHEALTH NOTIFICATION: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In NantHealth, Inc. To Contact The Firm
NEW YORK, March 7, 2017 /PRNewswire-USNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential securities fraud at NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ:NH)
Mar 07, 2017 08:01 am ET
NantHealth Investigated by Block & Leviton After Revelation That Company's Founder May Have Inflated Order Figures For Flagship Product
BOSTON, March 7, 2017 /PRNewswire/ -- Shares in NantHealth Inc. ("NantHealth" or the "Company") (NASDAQ: NH) plunged approximately 23% following an investigative report by Boston Globe Media's STAT. According to the report, the Company's founder, Patrick Soon-Shiong ("Dr. Soon") made a $12 million gift to the University of Utah with significant strings attached. Specifically, the gift's previously undisclosed terms required the University to spend $10 million with NantHealth for genetic sequencing work. According to STAT, NantHealth "counted the genetic tests done for the University of Utah
Mar 06, 2017 02:45 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NantHealth, Inc. - NH
NEW YORK, March 6, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH).   Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
Mar 06, 2017 02:23 pm ET
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of NantHealth, Inc. (NH)
NEW YORK, March 6, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of NantHealth, Inc. ("NantHealth" or the "Company") (NASDAQ: NH). Such investors are encouraged to obtain additional information and assist the investigation by visiting the firm's site: www.bgandg.com/nh.
Feb 03, 2017 05:00 am ET
Philadelphia Coalition for a Cure (PC4C) to Launch First of Its Kind Precision Medicine Study Supporting Collaborative Discovery for Brain Tumors with NantHealth's GPS Cancer Test Across Pediatric and
PHILADELPHIA, Feb. 3, 2017 /PRNewswire/ -- Philadelphia Coalition for a Cure (PC4C), a newly launched cooperative clinical diagnostics and research initiative announced that it will collaborate in a study together with Children's Hospital of Orange County (CHOC) directed to the study and diagnosis of adult and pediatric brain tumors.

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.